Baxter International has grown revenue −2.5% a year over three years and −1.2% a year over five. Revenue growth, 3-year annual rate: −2.5% (Medical Instruments & Supplies median +9.8%). Revenue growth, 5-year rate: −1.2%, growth has slowed since the five-year average. Years of annual history on file: 19, FY2007 to FY2025, as filed.

BAXBaxter International

Healthcare

$24.36+3.0% 1Y

$24.36

$15.7952 weeks$28.35

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though operating margin narrowing (−1.9 points).

1 to watch, 1 neutral, 1 without data

Revenue trend+5% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: −1% a year.

Margin direction−1.9 points operating

Trailing-twelve-month operating margin, -2.2% now against -0.3% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is BAX growing?

Baxter International has grown revenue −2.5% a year over three years and −1.2% a year over five.

−2.5%

Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +9.8% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −1.2%
Revenue growth, 5-year rate · −2.5% over three · growth has slowed since the five-year average
Years of annual history on file: 19
Years of annual history on file · FY2007 to FY2025, as filed

Details›